Adaptive Biotechnologies (ADPT) EV to FCF (2019 - 2026)

Adaptive Biotechnologies has disclosed EV to FCF across 8 years of filings, most recently posting 405.5 for Q2 2026.

• In Q2 2026, EV to FCF fell 236.79% year-over-year to 405.5; the TTM figure through Jun 2026 stood at 127.96 (down 572.55% YoY), while the FY2025 annual figure was 46.51, down 594.05% from the prior year.
• EV to FCF came in at 405.5 for Q2 2026 at Adaptive Biotechnologies, down from 194.15 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 1604.37 in Q4 2025 to a low of 405.5 in Q2 2026.
• Average EV to FCF over 5 years is 20.41, with a median of 18.48 recorded in 2022.
• The largest YoY upside for EV to FCF was 3143.64% in 2025 against a maximum downside of 1370.25% in 2025.
• Over 5 years, EV to FCF stood at 18.28 in 2022, then rose by 29.37% to 12.91 in 2023, then slumped by 308.38% to 52.71 in 2024, then jumped by 3143.64% to 1604.37 in 2025, then sank by 125.27% to 405.5 in 2026.
• Per Business Quant data, the three most recent EV to FCF figures were 405.5 in Q2 2026, 194.15 in Q1 2026, and 1604.37 in Q4 2025.